相似文献
1
The indications for the treatment of sarcoidosis: Wells Law.
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(4):280-282. doi: 10.36141/svdld.v34i4.6957. Epub 2017 Apr 28.
2
State-of-the-Art Treatments for Sarcoidosis.
Methodist Debakey Cardiovasc J. 2022 Mar 14;18(2):94-105. doi: 10.14797/mdcvj.1068. eCollection 2022.
3
Sarcoidosis: the clinical problem.
Postgrad Med J. 1988 Jul;64(753):531-5. doi: 10.1136/pgmj.64.753.531.
4
Current and emerging pharmacological treatments for sarcoidosis: a review.
Drug Des Devel Ther. 2013 Apr 12;7:325-38. doi: 10.2147/DDDT.S31064. Print 2013.
5
[Pharmacologic treatment of sarcoidosis].
Pneumologia. 2005 Apr-Jun;54(2):66-71.
6
Treatment indications for pulmonary sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis. 2016 Mar 29;33(1):98-9.
7
Indications for treatment of sarcoidosis.
Curr Opin Pulm Med. 2019 Sep;25(5):505-518. doi: 10.1097/MCP.0000000000000604.
8
A Case of Sarcoidosis Associated With Anti-Tumor Necrosis Factor Treatment.
J Investig Med High Impact Case Rep. 2015 Mar 9;3(1):2324709615571366. doi: 10.1177/2324709615571366. eCollection 2015 Jan-Mar.
9
FDG-PET Scan in Sarcoidosis: Clinical and Imaging Indications.
Curr Med Imaging Rev. 2019;15(1):4-9. doi: 10.2174/1573405614666180626120832.
10
Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review.
Adv Ther. 2022 Jul;39(7):3072-3087. doi: 10.1007/s12325-022-02176-4. Epub 2022 May 30.
引用本文的文献
1
Five principles and protocols for the clinician based on the 2021 ERS and BTS statements for treating sarcoidosis.
Lung India. 2024 Nov 1;41(6):459-463. doi: 10.4103/lungindia.lungindia_499_24. Epub 2024 Oct 29.
2
[Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024].
Wien Klin Wochenschr. 2024 Oct;136(Suppl 17):669-687. doi: 10.1007/s00508-024-02444-z. Epub 2024 Oct 9.
3
Hydroxychloroquine monotherapy in sarcoidosis: Indications, efficacy, and side effects.
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Sep 24;41(3):e2024039. doi: 10.36141/svdld.v41i3.15445.
4
[Not Available].
Tunis Med. 2023 Oct 5;101(10):765-769.
5
Pulmonary Cavitary Sarcoidosis: A Case Report.
Cureus. 2023 Oct 3;15(10):e46398. doi: 10.7759/cureus.46398. eCollection 2023 Oct.
6
The Symptoms of Pulmonary Sarcoidosis.
J Clin Med. 2023 Sep 20;12(18):6088. doi: 10.3390/jcm12186088.
7
An mTORC1-Dependent Mouse Model for Cardiac Sarcoidosis.
J Am Heart Assoc. 2023 Oct 3;12(19):e030478. doi: 10.1161/JAHA.123.030478. Epub 2023 Sep 26.
8
Health-related quality of life in cardiac sarcoidosis: a systematic review.
Eur Heart J Open. 2023 Feb 18;3(2):oead009. doi: 10.1093/ehjopen/oead009. eCollection 2023 Mar.
9
Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study.
BMJ Open Respir Res. 2022 Jul;9(1). doi: 10.1136/bmjresp-2022-001254.
10
Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis.
Diagnostics (Basel). 2021 Aug 28;11(9):1558. doi: 10.3390/diagnostics11091558.
本文引用的文献
1
Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension.
Eur Respir J. 2017 Oct 19;50(4). doi: 10.1183/13993003.00465-2017. Print 2017 Oct.
2
Predictors of Mortality in Pulmonary Sarcoidosis.
Chest. 2018 Jan;153(1):105-113. doi: 10.1016/j.chest.2017.07.008. Epub 2017 Jul 18.
3
Chronic pulmonary aspergillosis complicating sarcoidosis.
Eur Respir J. 2017 Jun 15;49(6). doi: 10.1183/13993003.02396-2016. Print 2017 Jun.
4
Quality of Life Assessment in Sarcoidosis.
Clin Chest Med. 2015 Dec;36(4):739-50. doi: 10.1016/j.ccm.2015.08.014. Epub 2015 Sep 11.
5
The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis.
Respir Med. 2015 Apr;109(4):526-31. doi: 10.1016/j.rmed.2015.01.019. Epub 2015 Feb 7.
6
HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.
Heart Rhythm. 2014 Jul;11(7):1305-23. doi: 10.1016/j.hrthm.2014.03.043. Epub 2014 May 9.
7
An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.
Lancet Respir Med. 2014 Feb;2(2):123-30. doi: 10.1016/S2213-2600(13)70276-5. Epub 2014 Jan 15.
8
Frequency of acute worsening events in fibrotic pulmonary sarcoidosis patients.
Respir Med. 2013 Dec;107(12):2009-13. doi: 10.1016/j.rmed.2013.10.014. Epub 2013 Oct 22.
9
The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States.
Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct;29(2):119-27.
10
Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial.
J Pain Symptom Manage. 2013 Feb;45(2):159-69. doi: 10.1016/j.jpainsymman.2012.02.016. Epub 2012 Aug 20.
Zotero 插件